Guided Therapeutics (GTHP) Other Non-Current Assets (2016 - 2026)
Guided Therapeutics (GTHP) posted Other Non-Current Assets of $17000.0 for Q4 2025, little changed sequentially from $17000.0 in Q3 2025, and little changed YoY from $17000.0 in Q4 2024.
Guided Therapeutics (GTHP) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Guided Therapeutics has reported Other Non-Current Assets for 10 years, with the latest figure at $17000.0 in Q4 2025.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $17000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $17000.0, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $17000.0 in Q4 2025 per GTHP's latest filing, from $17000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $18000.0 in Q1 2021 and troughed at $17000.0 in Q2 2021.
- A 5-year average of $17050.0 and a median of $17000.0 in 2021 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets advanced 5.88% in 2021, then dropped 5.56% in 2022.
- Over 5 years, Other Non-Current Assets stood at $17000.0 in 2021, then changed by 0.0% to $17000.0 in 2022, then changed by 0.0% to $17000.0 in 2023, then changed by 0.0% to $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $17000.0, $17000.0, and $17000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 17,000.00 |